Literature DB >> 26414467

Intraductal Carcinoma of the Prostate: Morphologic Features, Differential Diagnoses, Significance, and Reporting Practices.

Martin Magers1, Lakshmi Priya Kunju, Angela Wu.   

Abstract

The differential diagnosis for atypical cribriform lesions of the prostate has become increasingly complex and includes intraductal carcinoma of the prostate, high-grade prostatic intraepithelial neoplasia, and atypical intraductal proliferations. In this review, we summarize the morphologic and molecular features and significance of intraductal carcinoma of the prostate. We also summarize our institution's strategy for reporting and treatment recommendations for intraductal carcinoma of the prostate.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26414467     DOI: 10.5858/arpa.2015-0206-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells.

Authors:  Seong M Kim; Tricia T Nguyen; Archna Ravi; Peter Kubiniok; Brendan T Finicle; Vaishali Jayashankar; Leonel Malacrida; Jue Hou; Jane Robertson; Dong Gao; Jonathan Chernoff; Michelle A Digman; Eric O Potma; Bruce J Tromberg; Pierre Thibault; Aimee L Edinger
Journal:  Cancer Discov       Date:  2018-03-23       Impact factor: 39.397

Review 2.  [Intraductal carcinoma of the prostate].

Authors:  G Kristiansen; M Varma; G Seitz
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

Review 3.  Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.

Authors:  Maria Destouni; Andreas C Lazaris; Vasiliki Tzelepi
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

4.  Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer.

Authors:  Ning Xu; Zhi-Bin Ke; Ye-Hui Chen; Yu-Peng Wu; Shao-Hao Chen; Yong Wei; Qing-Shui Zheng; Jin-Bei Huang; Xiao-Dong Li; Xue-Yi Xue
Journal:  Front Oncol       Date:  2020-08-14       Impact factor: 6.244

5.  Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation.

Authors:  Pinuccia Faviana; Beatrice Belgio; Marco Panichi; Francesca Manassero; Cesare Selli; Laura Boldrini
Journal:  Urol Ann       Date:  2022-04-18

Review 6.  An Updated Review of Cribriform Carcinomas with Emphasis on Histopathological Diagnosis and Prognostic Significance.

Authors:  Giovanni Branca; Antonio Ieni; Valeria Barresi; Giovanni Tuccari; Rosario Alberto Caruso
Journal:  Oncol Rev       Date:  2017-03-10

Review 7.  WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.

Authors:  James G Kench; Mahul B Amin; Daniel M Berney; Eva M Compérat; Ian A Cree; Anthony J Gill; Arndt Hartmann; Santosh Menon; Holger Moch; George J Netto; Maria R Raspollini; Mark A Rubin; Puay Hoon Tan; Toyonori Tsuzuki; Samra Turjalic; Theo H van der Kwast; Ming Zhou; John R Srigley
Journal:  Histopathology       Date:  2022-08-02       Impact factor: 7.778

8.  Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.

Authors:  Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Jozien Helleman; Monique J Roobol; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2018-10-22       Impact factor: 7.842

Review 9.  Intraductal carcinoma of the prostate.

Authors:  Eszter Szentirmai; Giovanna Angela Giannico
Journal:  Pathologica       Date:  2020-03

Review 10.  Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information.

Authors:  Chao Han; Lina Zhu; Xiang Liu; Shuai Ma; Yi Liu; Xiaoying Wang
Journal:  Insights Imaging       Date:  2021-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.